文献速递肝胆胰外科围术期管理与 ERAS

多发性内分泌腺瘤病1型胰岛素瘤的手术治疗:胰十二指肠切除术的适用时机

Operation for insulinomas in multiple endocrine neoplasia type 1: When pancreatoduodenectomy is appropriate.
PubMed 文献 · Surgery · 2016-11-15

本文报告一个转诊中心1992至2015年间12例多发性内分泌腺瘤病1型胰岛素瘤的手术经验,其中8例行远端胰腺切除,4例行胰十二指肠切除术。结论推荐切除胰腺受累最严重部分并剜除保留胰腺内的大腺瘤,若胰头为最严重部位且合并佐林格-埃利森综合征,应优先选择胰十二指肠切除术。

要点

  • 切除胰腺受累最严重部分并剜除保留胰腺内大腺瘤可有效控制低血糖/高胰岛素综合征。
  • 胰头为最严重部位且合并佐林格-埃利森综合征时,优先选择胰十二指肠切除术。
  • 术后平均随访85个月,无临床复发,无患者发生糖尿病。

核心结论

  • 推荐切除胰腺受累最严重部分(左侧或右侧)并剜除保留胰腺内的大腺瘤,以治疗低血糖/高胰岛素综合征并预防无功能胰腺肿瘤恶变。
  • 若胰头为最严重部位且合并佐林格-埃利森综合征,胰十二指肠切除术应优先于远端胰腺切除术。

研究设计与样本

  • 单中心转诊病例系列,1992至2015年间共12例多发性内分泌腺瘤病1型胰岛素瘤患者接受手术。
  • 8例行远端胰腺切除,4例行胰十二指肠切除术;12例中9例同时对残留胰腺内其他大腺瘤行剜除术。

主要发现

  • 8例远端胰腺切除中4例发生手术并发症(2例胰瘘、2例胰腺炎),1例因首次手术并发症需再手术。
  • 病理分析显示5例有多发胰岛素瘤,2例淋巴结转移胰岛素阳性,全部患者有多发无功能胰腺肿瘤,4例有胰高血糖素瘤,4例十二指肠或淋巴结有胃泌素瘤。
  • 所有患者低血糖/高胰岛素综合征均获成功治疗,平均随访85个月(范围4-242个月)无临床复发。
  • 12例中仅1例残留胰腺复发无功能胰腺肿瘤大腺瘤,未见胃泌素瘤进展,无患者发生糖尿病。

临床怎么用

  • 对于多发性内分泌腺瘤病1型胰岛素瘤,应根据胰腺受累最严重部位决定切除范围,左侧或右侧均可。
  • 保留胰腺内若存在大腺瘤,应同时行剜除术以控制症状并预防无功能肿瘤恶变。
  • 当胰头为最严重受累部位且合并佐林格-埃利森综合征时,选择胰十二指肠切除术而非远端胰腺切除术。

局限性

  • 单中心回顾性病例系列,样本量小(12例),证据等级有限。
  • 随访时间范围跨度大(4-242个月),可能存在随访偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Distal pancreatectomy is the most frequent operation for insulinomas complicating multiple endocrine neoplasia type 1 insulinoma, although there are conditions for which a different operative approach might be preferable. In this article, we report the operative experience of a referral center for multiple endocrine neoplasia type 1 insulinoma. METHODS: Twelve patients underwent operations between 1992 and 2015: 8 underwent a distal pancreatic resection, and 4 underwent a pancreatoduodenectomy. Enucleation of other macroadenomas present in the remnant pancreas was performed in 9 out of these 12 patients. RESULTS: Operative complications (2 pancreatic fistulas and 2 cases of pancreatitis) occurred in 4 of the 8 distal pancreatic resections. In 1 patient, reoperation was required to resolve the complications of the first operation. At pathologic analysis, multiple insulinomas were found in 5 patients, lymph-nodal metastasis positive for insulin in 2 patients, multiple nonfunctioning pancreatic tumors in all patients, glucagonoma in 4 patients, and gastrinoma in the duodenum or lymph nodes in 4 patients. All the patients were treated successfully for the hypoglycemic/hyperinsulinemic syndrome with no clinical recurrence at a mean follow-up of 85 months (range 4-242 months). Recurrent nonfunctioning pancreatic tumor macroadenomas in the remnant pancreas occurred in only 1 of the 12 patients, and no progression of the gastrinomas was observed. None of the patients developed diabetes mellitus. CONCLUSION: Resection of the most severely affected part of the pancreas, whether left or right, associated with enucleation of concomitant macroadenomas in the preserved pancreas is recommended for the treatment of hypoglycemic/hyperinsulinemic syndrome and to prevent malignant progression of nonfunctioning pancreatic tumors in patients with multiple endocrine neoplasia type 1. If the head of the pancreas is the most affected site and the Zollinger-Ellison syndrome is concomitant, then pancreatoduodenectomy should be preferred over distal pancreatectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Tonelli F, Giudici F, Nesi G, et al. Operation for insulinomas in multiple endocrine neoplasia type 1: When pancreatoduodenectomy is appropriate. Surgery. 2016. PMID: 27863775. doi:10.1016/j.surg.2016.09.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。